For Brookfield Infrastructure Partners LP (NYSE:BIP), Raymond James upgraded the previous rating of Outperform to Strong Buy. Brookfield Infr Partners earned $0.38 in the second quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Brookfield Infr Partners shows a 52-week-high of $41.15 and a 52-week-low of $30.05. Moreover, at the end of the last trading period, the closing price was at $30.71.

Guggenheim upgraded the previous rating for Microsoft Corp (NASDAQ:MSFT) from Sell to Neutral. In the fourth quarter, Microsoft showed an EPS of $2.69, compared to $2.23 from the year-ago quarter. The current stock performance of Microsoft shows a 52-week-high of $366.78 and a 52-week-low of $213.46. Moreover, at the end of the last trading period, the closing price was at $317.01.

Loop Capital upgraded the previous rating for Clearwater Analytics Holdings Inc (NYSE:CWAN) from Hold to Buy. Clearwater Analytics Hldg earned $0.08 in the second quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $20.00 and a 52-week-low of $13.02. At the end of the last trading period, Clearwater Analytics Hldg closed at $19.67.

According to Citigroup, the prior rating for Sealed Air Corp (NYSE:SEE) was changed from Neutral to Buy. In the second quarter, Sealed Air showed an EPS of $0.80, compared to $1.01 from the year-ago quarter. The current stock performance of Sealed Air shows a 52-week-high of $56.43 and a 52-week-low of $31.25. Moreover, at the end of the last trading period, the closing price was at $31.41.

For AstraZeneca PLC (NASDAQ:AZN), Jefferies upgraded the previous rating of Hold to Buy. In the second quarter, AstraZeneca showed an EPS of $1.07, compared to $0.86 from the year-ago quarter. The current stock performance of AstraZeneca shows a 52-week-high of $76.56 and a 52-week-low of $52.66. Moreover, at the end of the last trading period, the closing price was at $67.83.

According to Noble Capital Markets, the prior rating for Lifeway Foods Inc (NASDAQ:LWAY) was changed from Outperform to Market Perform. In the second quarter, Lifeway Foods showed an EPS of $0.21, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.96 and a 52-week-low of $5.26. Lifeway Foods closed at $12.42 at the end of the last trading period.

Goldman Sachs downgraded the previous rating for Harmony Biosciences Holdings Inc (NASDAQ:HRMY) from Neutral to Sell. In the second quarter, Harmony Biosciences showed an EPS of $0.76, compared to $0.57 from the year-ago quarter. The stock has a 52-week-high of $61.94 and a 52-week-low of $29.81. At the end of the last trading period, Harmony Biosciences closed at $36.28.

Jefferies downgraded the previous rating for Urban Outfitters Inc (NASDAQ:URBN) from Buy to Hold. In the second quarter, Urban Outfitters showed an EPS of $1.10, compared to $0.64 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.81 and a 52-week-low of $18.76. Urban Outfitters closed at $31.90 at the end of the last trading period.

Barclays downgraded the previous rating for Plains GP Holdings LP (NASDAQ:PAGP) from Equal-Weight to Underweight. For the second quarter, Plains GP Holdings had an EPS of $0.25, compared to year-ago quarter EPS of $0.30. The current stock performance of Plains GP Holdings shows a 52-week-high of $16.70 and a 52-week-low of $10.45. Moreover, at the end of the last trading period, the closing price was at $16.61.

Barclays downgraded the previous rating for Plains All American Pipeline LP (NASDAQ:PAA) from Equal-Weight to Underweight. For the second quarter, Plains All American had an EPS of $0.25, compared to year-ago quarter EPS of $0.30. At the moment, the stock has a 52-week-high of $16.05 and a 52-week-low of $10.17. Plains All American closed at $15.79 at the end of the last trading period.

With a Buy rating, Craig-Hallum initiated coverage on Solo Brands Inc (NYSE:DTC). The price target seems to have been set at $8.00 for Solo Brands. In the second quarter, Solo Brands showed an EPS of $0.22, compared to $0.40 from the year-ago quarter. The current stock performance of Solo Brands shows a 52-week-high of $8.86 and a 52-week-low of $3.39. Moreover, at the end of the last trading period, the closing price was at $4.51.

With a Buy rating, Argus Research initiated coverage on Choice Hotels International Inc (NYSE:CHH). The price target seems to have been set at $145.00 for Choice Hotels Intl. For the second quarter, Choice Hotels Intl had an EPS of $1.75, compared to year-ago quarter EPS of $1.43. The current stock performance of Choice Hotels Intl shows a 52-week-high of $136.02 and a 52-week-low of $104.20. Moreover, at the end of the last trading period, the closing price was at $121.24.

Benchmark initiated coverage on Taboola.com Ltd (NASDAQ:TBLA) with a Buy rating. The price target for Taboola.com is set to $6.00. Taboola.com earned $0.00 in the second quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.45 and a 52-week-low of $1.52. Taboola.com closed at $3.74 at the end of the last trading period.

With a Buy rating, Alliance Global Partners initiated coverage on Vaccitech PLC (NASDAQ:VACC). The price target seems to have been set at $12.00 for Vaccitech. For the second quarter, Vaccitech had an EPS of $0.62, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $3.35 and a 52-week-low of $1.64. At the end of the last trading period, Vaccitech closed at $1.68.

UBS initiated coverage on Ziff Davis Inc (NASDAQ:ZD) with a Neutral rating. The price target for Ziff Davis is set to $81.00. Ziff Davis earned $1.27 in the second quarter, compared to $1.58 in the year-ago quarter. The current stock performance of Ziff Davis shows a 52-week-high of $94.45 and a 52-week-low of $58.08. Moreover, at the end of the last trading period, the closing price was at $66.61.

UBS initiated coverage on TechTarget Inc (NASDAQ:TTGT) with a Neutral rating. The price target for TechTarget is set to $31.00. In the second quarter, TechTarget showed an EPS of $0.45, compared to $0.68 from the year-ago quarter. The current stock performance of TechTarget shows a 52-week-high of $68.15 and a 52-week-low of $26.01. Moreover, at the end of the last trading period, the closing price was at $26.57.

With an Outperform rating, Wedbush initiated coverage on Pharvaris NV (NASDAQ:PHVS). The price target seems to have been set at $27.00 for Pharvaris. In the second quarter, Pharvaris showed an EPS of $0.69, compared to $0.40 from the year-ago quarter. The current stock performance of Pharvaris shows a 52-week-high of $26.86 and a 52-week-low of $1.80. Moreover, at the end of the last trading period, the closing price was at $20.32.

With a Buy rating, Canaccord Genuity initiated coverage on Hudson Technologies Inc (NASDAQ:HDSN). The price target seems to have been set at $15.00 for Hudson Technologies. For the second quarter, Hudson Technologies had an EPS of $0.41, compared to year-ago quarter EPS of $0.59. The current stock performance of Hudson Technologies shows a 52-week-high of $13.34 and a 52-week-low of $6.62. Moreover, at the end of the last trading period, the closing price was at $12.10.

With a Buy rating, HSBC initiated coverage on Plug Power Inc (NASDAQ:PLUG). The price target seems to have been set at $11.00 for Plug Power. Plug Power earned $0.40 in the second quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $25.50 and a 52-week-low of $7.33. At the end of the last trading period, Plug Power closed at $7.43.

With a Buy rating, HC Wainwright & Co. initiated coverage on AngioDynamics Inc (NASDAQ:ANGO). The price target seems to have been set at $19.00 for AngioDynamics. In the fourth quarter, AngioDynamics showed an EPS of $0.02, compared to $0.01 from the year-ago quarter. The current stock performance of AngioDynamics shows a 52-week-high of $21.86 and a 52-week-low of $6.71. Moreover, at the end of the last trading period, the closing price was at $7.02.

UBS initiated coverage on The Chefs' Warehouse Inc (NASDAQ:CHEF) with a Buy rating. The price target for The Chefs' Warehouse is set to $37.00. In the second quarter, The Chefs' Warehouse showed an EPS of $0.35, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $39.50 and a 52-week-low of $22.30. At the end of the last trading period, The Chefs' Warehouse closed at $23.26.

UBS initiated coverage on Warby Parker Inc (NYSE:WRBY) with a Neutral rating. The price target for Warby Parker is set to $13.00. In the second quarter, Warby Parker showed an EPS of $0.04, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $18.97 and a 52-week-low of $9.50. At the end of the last trading period, Warby Parker closed at $12.35.

With a Market Outperform rating, JMP Securities initiated coverage on Sana Biotechnology Inc (NASDAQ:SANA). The price target seems to have been set at $9.00 for Sana Biotechnology. For the second quarter, Sana Biotechnology had an EPS of $0.45, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $8.01 and a 52-week-low of $2.99. At the end of the last trading period, Sana Biotechnology closed at $3.83.

JMP Securities initiated coverage on Ambrx Biopharma Inc (NASDAQ:AMAM) with a Market Outperform rating. The price target for Ambrx Biopharma is set to $15.00. In the second quarter, Ambrx Biopharma showed an EPS of $0.35, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.86 and a 52-week-low of $0.38. Ambrx Biopharma closed at $11.32 at the end of the last trading period.

Goldman Sachs initiated coverage on Alector Inc (NASDAQ:ALEC) with a Sell rating. The price target for Alector is set to $4.00. Alector earned $0.02 in the second quarter, compared to $0.12 in the year-ago quarter. The current stock performance of Alector shows a 52-week-high of $10.03 and a 52-week-low of $4.98. Moreover, at the end of the last trading period, the closing price was at $6.88.

With a Neutral rating, Goldman Sachs initiated coverage on Fulcrum Therapeutics Inc (NASDAQ:FULC). The price target seems to have been set at $5.00 for Fulcrum Therapeutics. Fulcrum Therapeutics earned $0.38 in the second quarter, compared to $0.83 in the year-ago quarter. The current stock performance of Fulcrum Therapeutics shows a 52-week-high of $15.00 and a 52-week-low of $2.25. Moreover, at the end of the last trading period, the closing price was at $4.17.